Literature DB >> 12409151

31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism.

Juliana Yacubian1, Claudio Campi de Castro, Mariella Ometto, Elizabeth Barbosa, Cândida Pires de Camargo, Hildeberto Tavares, Giovanni Guido Cerri, Wagner Farid Gattaz.   

Abstract

Studies using 31P-magnetic resonance spectroscopy (MRS) reported on abnormalities in frontal lobe metabolism in schizophrenia. The most consistent findings were a reduction in the resonances of phosphomonoesters (PME) and/or increased phosphodiesters (PDE), which are, respectively, the precursors and the metabolites of membrane phospholipids, thus suggesting an accelerated phospholipid metabolism in the disease. Other studies reported increased high-energy phosphates (ATP-adenosine triphosphate and PCr-phosphocreatine) in schizophrenia, reflecting decreased use of energy in the frontal lobe. We investigated 53 schizophrenic patients (DSM-IV) and 35 healthy controls. Eighteen from these patients were drug nai;ve and the remaining 35 were drug-free for an average of 6 months. Phospholipid metabolism and high-energy phosphates were assessed in the left frontal lobe using 31P-MRS. Psychopathological evaluation was done with the Brief Psychiatric Rating Scale (BPRS) and the Negative Symptoms Rating Scale (NSRS). Neuropsychological evaluation was performed with the Wisconsin Card Sorting Test (WCST), Stroop Test and Wechsler Adult Intelligence Scale. Drug-nai;ve patients showed reduced PDE in the left frontal lobe compared to controls and to previously medicated patients (p<0.05). No differences among the three groups were found regarding the other spectroscopy parameters. In healthy controls, but not in schizophrenics, a negative (and probably physiological) correlation was found between PME and PDE (p<0.01). In schizophrenic patients, ATP was correlated with negative symptoms and with neuropsychological impairment (p<0.01). The lack of a correlation between PME and PDE, as well as the reduction of PDE in schizophrenia, suggest a disrupted phospholipid metabolism in the disease, albeit on a contrary direction of that reported in literature. The relationships of ATP with negative symptoms and neuropsychological deficit suggest an alteration of energetic demand in the frontal lobe of schizophrenic patients, which is in line with the hypofrontality hypothesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409151     DOI: 10.1016/s0920-9964(01)00394-2

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

1.  Genetic variant in NDUFS1 gene is associated with schizophrenia and negative symptoms in Han Chinese.

Authors:  Yunlong Zhu; Zhongliang Wang; Jianliang Ni; Yi Zhang; Meijuan Chen; Jun Cai; Xiao Li; Wen Zhang; Chen Zhang
Journal:  J Hum Genet       Date:  2014-10-30       Impact factor: 3.172

2.  Abnormal synaptic pruning in schizophrenia: Urban myth or reality?

Authors:  Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

3.  Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study.

Authors:  Orestes V Forlenza; Priscilla Wacker; Paula V Nunes; Juliana Yacubian; Claudio C Castro; Maria C G Otaduy; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-08       Impact factor: 4.530

Review 4.  Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?

Authors:  Andreas Konrad; Georg Winterer
Journal:  Schizophr Bull       Date:  2007-05-07       Impact factor: 9.306

5.  PH Measurements of the Brain Using Phosphorus Magnetic Resonance Spectroscopy ((31)PMRS) in Healthy Men - Comparison of Two Analysis Methods.

Authors:  Monika Cichocka; Justyna Kozub; Andrzej Urbanik
Journal:  Pol J Radiol       Date:  2015-11-21

6.  Psychiatric neuroimaging research in Brazil: historical overview, current challenges, and future opportunities.

Authors:  Geraldo Busatto Filho; Pedro G Rosa; Mauricio H Serpa; Paula Squarzoni; Fabio L Duran
Journal:  Braz J Psychiatry       Date:  2020-06-08       Impact factor: 2.697

7.  Metabolic changes in schizophrenia and human brain evolution.

Authors:  Philipp Khaitovich; Helen E Lockstone; Matthew T Wayland; Tsz M Tsang; Samantha D Jayatilaka; Arfu J Guo; Jie Zhou; Mehmet Somel; Laura W Harris; Elaine Holmes; Svante Pääbo; Sabine Bahn
Journal:  Genome Biol       Date:  2008-08-05       Impact factor: 13.583

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.